Concepedia

Qiankun Zhu

QZ

Statistics

Publications

3

Citations

78

H-Index

3

Active since

2020

Affiliations

Harbin Medical University(Current)

Fourth Affiliated Hospital of Harbin Medical University

Qiankun Zhu is an author at Harbin Medical University specializing in pharmacology, anticancer drug resistance, and therapeutic resistance mechanisms.

Publications per year

2020–2022

3

Publications

3

PD-L1 monoclonal antibody-decorated nanoliposomes loaded with Paclitaxel and P-gp transport inhibitor for the synergistic chemotherapy against multidrug resistant gastric cancers

Jinling Yu, Fengli Hu, Qiankun Zhu et al. · Nanoscale Research Letters · 2020 · 36 citations · Full text

, , +17

TOP2A inhibition reverses drug resistance of hepatocellular carcinoma to regorafenib.

Zongwen Wang, Qiankun Zhu, Xiaodong Li et al. · PubMed · 2022 · 28 citations · Full text

, , +17

Silencing <italic>KIF14</italic> reverses acquired resistance to sorafenib in hepatocellular carcinoma

Qiankun Zhu, Haiyang Ren, Xiaodong Li et al. · Aging · 2020 · 14 citations · Full text

, , +17

1–3 of 3